DE69902684T2 - Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11 - Google Patents

Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11

Info

Publication number
DE69902684T2
DE69902684T2 DE69902684T DE69902684T DE69902684T2 DE 69902684 T2 DE69902684 T2 DE 69902684T2 DE 69902684 T DE69902684 T DE 69902684T DE 69902684 T DE69902684 T DE 69902684T DE 69902684 T2 DE69902684 T2 DE 69902684T2
Authority
DE
Germany
Prior art keywords
estrogen receptor
carbon atoms
compounds
beta
receptor alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69902684T
Other languages
English (en)
Other versions
DE69902684D1 (de
Inventor
Jan Loozen
Gerardus Schoonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69902684D1 publication Critical patent/DE69902684D1/de
Application granted granted Critical
Publication of DE69902684T2 publication Critical patent/DE69902684T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69902684T 1998-11-20 1999-11-18 Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11 Expired - Lifetime DE69902684T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203914 1998-11-20
PCT/EP1999/009053 WO2000031112A1 (en) 1998-11-20 1999-11-18 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11

Publications (2)

Publication Number Publication Date
DE69902684D1 DE69902684D1 (de) 2002-10-02
DE69902684T2 true DE69902684T2 (de) 2003-04-24

Family

ID=8234361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69902684T Expired - Lifetime DE69902684T2 (de) 1998-11-20 1999-11-18 Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11

Country Status (6)

Country Link
US (1) US7528123B1 (de)
EP (1) EP1131336B1 (de)
AT (1) ATE222922T1 (de)
AU (1) AU1967300A (de)
DE (1) DE69902684T2 (de)
WO (1) WO2000031112A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19929715A1 (de) * 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
MXPA02010066A (es) * 2000-04-12 2003-06-04 Schering Ag Estratrienos sustituidos en 8beta-hidrocarbilo para uso como estrogenos selectivos.
BR0112791A (pt) 2000-07-28 2003-06-24 Akzo Nobel Nv Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
US6884814B2 (en) 2001-12-13 2005-04-26 Wyeth Phenyl benzisoxazoles as estrogenic agents
US6835745B2 (en) 2002-01-15 2004-12-28 Wyeth Phenyl substituted thiophenes as estrogenic agents
US7235539B2 (en) 2002-01-23 2007-06-26 Wyeth 6-Hydroxyequilenins as estrogenic agents
US9315539B2 (en) 2002-10-01 2016-04-19 Yale University 11 beta-short chain substituted estradiol analogs and their use in the treatment of menopausal symptoms and estrogen sensitive cancer
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
JP5456669B2 (ja) 2007-05-03 2014-04-02 エール ユニヴァーシティ 局所活性「ソフト」抗アンドロゲン剤
CZ300376B6 (cs) 2008-05-05 2009-05-06 Prírodovedecká Fakulta Uk Ligandy estrogenových receptoru alfa a beta, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují
US10918648B2 (en) 2016-05-26 2021-02-16 The Regents Of The University Of California Estrogen receptor modulator combinations
EP3801501A4 (de) * 2018-06-06 2022-03-23 The Regents of the University of California Östrogenrezeptorinhibitoren und deren verwendungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755301A (en) * 1972-06-23 1973-08-28 Searle & Co Manufacture of 11-alkyl steroids
DE4132182A1 (de) 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor

Also Published As

Publication number Publication date
EP1131336B1 (de) 2002-08-28
AU1967300A (en) 2000-06-13
ATE222922T1 (de) 2002-09-15
US7528123B1 (en) 2009-05-05
WO2000031112A1 (en) 2000-06-02
DE69902684D1 (de) 2002-10-02
EP1131336A1 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
DE69902684T2 (de) Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11
IL122348A0 (en) Neuroactive steroids of the androstane and pregnane series
ATE347365T1 (de) Verwendung von öestrogen in kombination mit progestogen für die hormonsubstitutions-therapie
HRP20020892B1 (en) 8c-hydrocarbyl-substituted estratrienes for use as selective estrogens
ES2121570T3 (es) Derivados de androgenos para uso en la inhibicion de la actividad de los esteroides sexuales.
PT680327E (pt) Utilizacoes terapeuticas e sistemas de distribuicao de desidroepiandrosterona
BR9710074A (pt) "bisfosfanatos esteróides"
EP1310508A3 (de) Oestrogen-Sulfamate als Sulfataseinhibitoren
KR880012633A (ko) C_17 내지 C_20 리아제 억제제로서 유용한 17β-(사이클로프로필아미노)안드로스트-5-엔-3β-올 및 관련 화합물
BR0013769A (pt) Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide
NZ511705A (en) Methods and rapid immunoassay device for detecting progesterone and other steroids
MX9702252A (es) Nuevos androstanos para inducir efectos hipotalamicos.
AR246870A1 (es) Procedimiento para preparar una composicion para efectuar anticoncepcion en hombres.
RU97107609A (ru) Новые эстрены для индукции эффектов гипоталамуса
PE20010579A1 (es) Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos
ATE193878T1 (de) Substituierte dibenz(a,f)azulene und verfahren zu ihrer herstellung
PT1196428E (pt) Esteroides substituidos com 11 beta-aril-17, 17-espirotiolano
PE20010581A1 (es) Mesoprogestinas (modulares de receptores de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (hrt)
HK1052012A1 (en) 16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity.
EP0139907A3 (en) Estrane derivatives
ES2196264T3 (es) Compuestos b nor-6-tiaequilenina 8-sustituidos que tienen actividad como moduladores selectivos de los receptores de estrogenos.
EP0402963A3 (de) 17-Alpha-Ethynyl Steroide
ES387604A1 (es) Procedimiento para la obtencion de 17 alfa - (alquilo infe-rior alenilcarbinoles.
KR910000160A (ko) 17-시클로프로필아미노안드로스텐 유도체를 함유한 알도스테론 억제제
GB1091999A (en) Steroidal compounds and a process for their preparation

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL

8364 No opposition during term of opposition